Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
headphones
S&P Pharma Dose

S&P Pharma Dose

S&P Global Ratings

Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&P Pharma Dose podcast from S&P Global Ratings discusses all things pharma from a credit perspective.
bookmark
Share icon

All episodes

Best episodes

Top 10 S&P Pharma Dose Episodes

Goodpods has curated a list of the 10 best S&P Pharma Dose episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to S&P Pharma Dose for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite S&P Pharma Dose episode by adding your comments to the episode page.

In this episode, healthcare analyst Arthur Wong shares his thoughts on the potential rise of company healthcare exchanges and what impact these entities may have on the pharmaceutical industry and pharmaceutical company ratings.

bookmark
plus icon
share episode

S&P Global Ratings' senior pharma analyst, Ji Liu, discusses the puts and takes for our new Regeneron Pharmaceuticals ratings.

bookmark
plus icon
share episode
S&P Pharma Dose - Episode 34: More Color on PPD’s Rating After IPO
play

02/11/20 • 6 min

In this episode of S&P Pharma Dose, senior healthcare analyst Ji Liu discusses his view on Pharmaceutical Product Development LLC (PPD) after its recent IPO on Feb. 5, 2020.

bookmark
plus icon
share episode

The S&P Pharma Guy, Arthur Wong, shares S&P Global's initial thoughts on President Trump's recent speech on lowering drug prices. The speech questioned the validity of drug rebates and criticized foreign countries for paying too little for drugs, but stopped short of limiting proposing pharma list price increases or enabling Medicare to negotiate directly for pricing. Limited credit impact?

bookmark
plus icon
share episode

The S&P Pharma Guy, Arthur Wong, shares why generic drug pricing in the U.S., which has been under increasing pressure, should begin to stabilize in 2018. However, the U.S. generic drug environment will likely remain challenging over the near term and S&P harbors longer-term concerns on the industry.

bookmark
plus icon
share episode
S&P Pharma Dose - Episode 25: Four Things We Are Watching For On Teva
play

12/07/17 • 18 min

The S&P Pharma Guy, Arthur Wong details four things S&P is watching for on Teva over the next three quarters that would help determine whether the ratings stay investment grade.

bookmark
plus icon
share episode

S&P Global Ratings analyst Arthur Wong takes an early look as to what a possible entry of Amazon.com Inc. into the pharma ecosystem may mean to drug pricing for generic and branded pharma. Warning: More questions than answers at this point.

bookmark
plus icon
share episode
S&P Pharma Dose - Episode 22: Reflections - Mylan NV Earnings 2Q17
play

09/06/17 • 11 min

Guest analyst, Kim Logan, drops in to share her reflections on generic giant Mylan NV's second quarter performance and shares her thoughts on the company maintaining investment grade ratings.

bookmark
plus icon
share episode

In this episode, healthcare analyst Matt Todd chats about what is driving the recent positive ratings actions in the contract research organization (CRO) space.

bookmark
plus icon
share episode

S&P Global’s pharmaceutical themed podcast show returns with some quick thoughts on the pharma industry’s testimony at a congressional hearing on Capitol Hill. A comprehensive list of challenges/criticisms of the industry, but where were the suggested solutions? Noise level on pharma pricing is only going to increase as we near presidential election.

bookmark
plus icon
share episode

Show more best episodes

Toggle view more icon

FAQ

How many episodes does S&P Pharma Dose have?

S&P Pharma Dose currently has 35 episodes available.

What topics does S&P Pharma Dose cover?

The podcast is about News, Pharma, Business News, Podcasts, Business and Industry.

What is the most popular episode on S&P Pharma Dose?

The episode title 'Episode 33: Pharmacy Benefit Manager Industry In 2020: Less Regulatory Overhang, Expect More Consolidations' is the most popular.

What is the average episode length on S&P Pharma Dose?

The average episode length on S&P Pharma Dose is 11 minutes.

How often are episodes of S&P Pharma Dose released?

Episodes of S&P Pharma Dose are typically released every 23 days.

When was the first episode of S&P Pharma Dose?

The first episode of S&P Pharma Dose was released on Feb 25, 2016.

Show more FAQ

Toggle view more icon

Comments